🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesEchocardiographic changes on GLP-1 — LV mass and diastolic function Page 4

Echocardiographic changes on GLP-1 — LV mass and diastolic function

Dr.CardioMD Sat, May 30, 2026 at 6:58 AM 20 replies 460 viewsPage 4 of 4
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
May 30, 2026 at 12:38 PM#16

Congrats Dr.MetabolicMD!! Keep going — you're doing incredible. 🎉 👏

Last edited: May 30, 2026 at 3:38 PM
1 16DoseLogDan
Reply Quote Save Share Report
hannah_MT
New Member
23
89
Feb 2026
Bozeman, MT
May 30, 2026 at 12:55 PM#17

Saving this for reference. Top-tier content.

Last edited: May 30, 2026 at 3:55 PM
6 2MounjBrad, nick_newbie, DadBodDave and 3 others
Reply Quote Save Share Report
LeilaHI
Member
167
789
Jan 2025
Honolulu, HI
May 30, 2026 at 1:12 PM#18

Want to share my personal experience related to Echocardiographic changes on since I think it might help others in a similar situation.

I started my GLP-1 journey in March 2025 at 289 lbs with metabolic syndrome. My telehealth provider prescribed semaglutide 0.25mg to start.

Now, 12 months later: I am down 39 lbs, my labs have normalized, and my sleep apnea has improved dramatically. The Echocardiographic aspect specifically was something that made a big difference in my journey.

This forum was my go-to resource throughout.

Last edited: May 30, 2026 at 6:12 PM
32 9mike_nyc, VendorMark, COA_Karl and 29 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
May 30, 2026 at 1:29 PM#19

Relevant to Echocardiographic changes on — here is my latest bloodwork comparison:

Key improvements: A1C 8.0% → 5.3%, triglycerides 235 → 105 mg/dL, hsCRP 6.0 → 1.1 mg/L. All on tirzepatide for 15 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

13 16DebRD_ATL, KristenIndy, MarkLI_maint and 10 others
Reply Quote Save Share Report
nick_newbie
New Member
18
56
Jun 2026
Virginia
Online
May 30, 2026 at 1:46 PM#20

Want to share my personal experience related to Echocardiographic changes on since I think it might help others in a similar situation.

I started my GLP-1 journey in October 2024 at 261 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.

Now, 18 months later: I am down 46 lbs, my labs have normalized, and I am off 2 of my 3 medications. The Echocardiographic aspect specifically was something that made a big difference in my journey.

This community helped me every step of the way.

Last edited: May 30, 2026 at 4:46 PM
36 0wanda_boise, NurseAsh_DET, BenResearch_OR and 33 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register